Localized Upper Tract Urothelial Carcinoma
Peter Schulam MD, PhD, compares and contrasts the Surveillance, Epidemiology, and End Results (SEER) database and the National Cancer Database (NCDB) in terms of reliability for assessing upper tract urothelial carcinoma (UTUC) outcomes and risk factors when determining whether to treat a patient with definitive therapy or the “Watchful Waiting” strategy.
▶︎
Upper Tract Urothelial Carcinoma - EMPIRE Urology In Service Review
▶︎
Upper-Tract Urothelial Cancer Guidelines Webcast (2023)
▶︎
Don't Biopsy Your Prostate Until You Hear This (Part 2)
▶︎
Upper Tract Urothelial Cancer & Urethral Cancer
▶︎
Kidney Preservation for Upper-Tract Urothelial Carcinoma: Current State and Future Directions
▶︎
The French Do Not Care About Work
▶︎
She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳
▶︎
Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows
▶︎
Former nurse speaks out after sentencing in fatal drug error | Nightline
▶︎
Pancreas Cancer: What Patients Need to Know
▶︎
Targeting FGFR in urothelial carcinoma
▶︎
Renal Cell Carcinoma (RCC) - Kidney Tumors - Neoplasms - Renal Pathology - Nephrology
▶︎
The Evolving Treatment of Upper Tract Urothelial Carcinoma (UTUC)
▶︎
Radiation Therapy: Long Term & Short Term Side Effects #ProstateCancer | #MarkScholzMD #AlexScholz
▶︎
Why Returning From Mars Is Impossible: Feynman's Warning
▶︎
"This Is Feeding Cancer Cells!" - Fix This To Starve Disease & Heal The Body | Thomas Seyfried
▶︎
The Latest Guidelines for UTUC With Dr. Peter Clark
▶︎
The Kidney and Kidney Cancers | UCLA Urology
▶︎
Management of High Risk NMIBC—What’s New in Intravesical Therapy | Treatment of Bladder Cancer
▶︎